See what Medtronic, Zimmer Biomet, and Pear Therapeutics were up to this time last year.

Katie Hobbins, Managing Editor

March 23, 2023

2 Min Read
Calendar pages
Archive Holdings Inc. / The Image Bank via Getty Images

Diabetes Tech’s Latest Player Is Debuting April 1

Becton Dickinson & Co. gave an update on the launch of Embecta, its diabetes spinoff.

Theranos Saga: What's up with Sunny's Trial?

Opening arguments in the trial of Ramesh “Sunny” Balwani, former president and chief operating officer at Theranos, will now begin Tuesday morning. But is something more brewing behind the scenes in this case?

Eko Launches Redesigned App to Screen for Heart Disease

FDA’s clearances are for artificial intelligence (AI) algorithms that detect leading indicators of heart disease.

Medtronic Isn't Ready to Throw in the Towel on Renal Denervation Just Yet

Medtronic still seems confident about its renal denervation opportunity, but investors have "mostly given up," a medtech analyst observes.

Biocomposites Teams Up with Zimmer Biomet to Offer New Bone Graft Substitute in the U.S.

The U.K.-based company has devised new mixing and delivery systems for the U.S. orthopedic market to save time and meet surgeon preferences.

EpiShuttle for Patient Isolation & Transport Tapped for Emergency Preparations

The single-patient stretcher has been selected by Leader Healthcare for use in Qatar and the United Arab Emirates.

Paper Device Aims to Make a Big Impact

The award-winning eco・pí Urine Sample Collector seeks to solve a common problem in a sustainable way.

Can Medtech Help Address the Top 10 Patient Safety Concerns of 2022?

ECRI has released its annual list of patient safety concerns, and this year patients could really be feeling the long-term effects of the COVID-19 pandemic.

Gone Are the Days of Europe-First Medical Device Innovation

Pursuing regulatory approval in Europe first has lost its appeal, according to an explosive new industry survey.

Pear Looks to Fruitful Japanese Sleep Market

The company is working with SoftBank to develop a Japanese-language digital therapeutic for the treatment of sleep/wake disorders.

HLT Developing TAVR System with Broader Offerings to Compete

The Maple Grove, MN-based company has won FDA approval for two clinical studies assessing the HLT Meridian TAVR Valve System.

Manufacturing Strategies for Commercializing Novel IVD Technologies

Consider these manufacturing challenges faced by original equipment manufacturers working to commercialize innovative technologies in the IVD sector.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like